XplantR is priced at $4,900 per unit — less than the cost of a single extra hour in a vascular OR, and a fraction of what one avoidable aortic tissue injury can cost in outcomes, revision, and liability.

90 sec avg. explant time (30 surgeons, FDA De Novo study) • 0 instances of intimal damage beyond fixation puncture marks (n=120) • 2 US patents issued

• Built for one job — the first purpose-built instrument for open EVAR explant, replacing modified syringes and orthopedic wire cutters never designed for aortic tissue.

• 90 seconds, not 30+ minutes — in the FDA De Novo study, 30 vascular surgeons averaged just 90 seconds per explant, start to finish.

• Zero intimal damage, by design — across all 120 De Novo study explants, inspection found no damage beyond the original suprarenal fixation puncture marks.

“At $4,900, XplantR costs less than 20 minutes of OR time — and it’s built to make sure you don’t need the other 40.”

FDA De Novo Authorized • Co-developed with MCW Vascular Surgery • 2 US Patents Issued